Traded Aug 8, 2026 · largest single transaction 1,600
Show all 2 transactions
Aug 8, 20261,600
DetailsOfficial recordAug 8, 20261,600
DetailsOfficial record
Ask OQRO reads the filings behind this page and answers in plain words, with a link to each source.
Ask OQRO is part of OQRO Pro. Everything else on OQRO is free.
Only to see which pages are hard to use, so we can fix them. Nothing is used for ads, and what you type stays hidden (Microsoft Clarity, PostHog). Privacy Policy
PCSA · NASDAQ · Pharmaceutical Preparations
Processa Pharmaceuticals (PCSA) · oqro.io/stocks/PCSA · printed today. Every figure comes from a public filing, linked on the page online. Not investment advice.
$1.56−0.13 (−7.69%)
Close of Nov 20, 2026, vs Nov 19 · end-of-day
Including 28 routine filings (option exercises, tax withholding, grants, gifts). Open-market trades only
Traded Aug 8, 2026 · largest single transaction 1,600
Aug 8, 20261,600
DetailsOfficial recordAug 8, 20261,600
DetailsOfficial recordTraded Jul 28, 2026 · largest single transaction 71K
Jul 28, 202671K
DetailsOfficial recordJul 28, 202612K
Insider filing
Traded Jul 26 · filed 3 days later
Compensation award — excluded from discretionary-purchase analysis.
Insider filing
Traded Jul 26 · filed 3 days later
Compensation award — excluded from discretionary-purchase analysis.
Insider filing
Traded Jul 26 · filed 3 days later
Compensation award — excluded from discretionary-purchase analysis.
Insider filing
Traded Jul 26 · filed 3 days later
Compensation award — excluded from discretionary-purchase analysis.
Insider filing
Traded Jul 26 · filed 3 days later
Compensation award — excluded from discretionary-purchase analysis.
Insider filing
Traded Jul 26 · filed 3 days later
Compensation award — excluded from discretionary-purchase analysis.
Insider filing
Traded Jul 26 · filed 3 days later
Compensation award — excluded from discretionary-purchase analysis.
Insider filing
Traded Jul 26 · filed 3 days later
Compensation award — excluded from discretionary-purchase analysis.
Insider buying
5 insiders in a week, 4th time since 2020Traded Jul 1 · filed 1 day later
Since the trade −20.4% · S&P 500 −7.5% · to Nov 20
Bought 84% below the 52-week high, RSI 40, 53% under its 200-day average, 37 points behind the S&P 500 over 3 months
Insider buying
4 insiders in a week, 6th time since 2020Traded Jun 30 · filed 2 days later
Since the trade −18.8% · S&P 500 −7.6% · to Nov 20
Bought within 4% of the 52-week low, RSI 38, 54% under its 200-day average, 48 points behind the S&P 500 over 3 months
Insider buying
4 insiders in a week, 6th time since 2020Traded Jun 30 · filed 2 days later
Since the trade −18.8% · S&P 500 −7.6% · to Nov 20
Bought within 4% of the 52-week low, RSI 38, 54% under its 200-day average, 48 points behind the S&P 500 over 3 months
Insider buying
4 insiders in a week, 6th time since 2020Traded Jun 30 · filed 2 days later
Since the trade −18.8% · S&P 500 −7.6% · to Nov 20
Bought within 4% of the 52-week low, RSI 38, 54% under its 200-day average, 48 points behind the S&P 500 over 3 months
Insider buying
4 insiders in a week, 6th time since 2020Traded Jun 30 · filed 2 days later
Since the trade −18.8% · S&P 500 −7.6% · to Nov 20
Bought within 4% of the 52-week low, RSI 38, 54% under its 200-day average, 48 points behind the S&P 500 over 3 months
Traded Jun 26, 2026 · largest single transaction 203
Jun 26, 2026203
DetailsOfficial recordJun 26, 2026203
Traded Jun 26, 2026 · largest single transaction 203
Jun 26, 2026203
DetailsOfficial recordJun 26, 2026203
Traded Jun 26, 2026 · largest single transaction 203
Jun 26, 2026203
DetailsOfficial recordJun 26, 2026203
Traded Jun 26, 2026 · largest single transaction 203
Jun 26, 2026203
DetailsOfficial recordJun 26, 2026203
Insider buying
5 insiders in a week, 3rd time since 2020Traded Jun 15 · filed 2 days later
Since the trade −29.4% · S&P 500 −8.6% · to Nov 20
Bought 82% below the 52-week high, RSI 43, 49% under its 200-day average, 42 points behind the S&P 500 over 3 months
Insider buying
5 insiders in a week, 3rd time since 2020Traded Jun 15 · filed 2 days later
Since the trade −29.4% · S&P 500 −8.6% · to Nov 20
Bought 82% below the 52-week high, RSI 43, 49% under its 200-day average, 42 points behind the S&P 500 over 3 months
Insider buying
5 insiders in a week, 3rd time since 2020Traded Jun 15 · filed 2 days later
Since the trade −29.4% · S&P 500 −8.6% · to Nov 20
Bought 82% below the 52-week high, RSI 43, 49% under its 200-day average, 42 points behind the S&P 500 over 3 months
Insider buying
5 insiders in a week, 3rd time since 2020Traded Jun 15 · filed 2 days later
Since the trade −29.4% · S&P 500 −8.6% · to Nov 20
Bought 82% below the 52-week high, RSI 43, 49% under its 200-day average, 42 points behind the S&P 500 over 3 months
Insider buying
5 insiders in a week, 3rd time since 2020Traded Jun 15 · filed 2 days later
Since the trade −29.4% · S&P 500 −8.6% · to Nov 20
Bought 82% below the 52-week high, RSI 43, 49% under its 200-day average, 42 points behind the S&P 500 over 3 months
Insider buying
5 insiders in a week, 3rd time since 2020Traded May 29 · filed 4 days later
Since the trade −39.1% · S&P 500 −8.8% · to Nov 20
Bought 79% below the 52-week high, RSI 46, 43% under its 200-day average
Insider buying
5 insiders in a week, 3rd time since 2020Traded May 29 · filed 4 days later
Since the trade −39.1% · S&P 500 −8.8% · to Nov 20
Bought 79% below the 52-week high, RSI 46, 43% under its 200-day average
Insider buying
5 insiders in a week, 3rd time since 2020Traded May 29 · filed 4 days later
Since the trade −39.1% · S&P 500 −8.8% · to Nov 20
Bought 79% below the 52-week high, RSI 46, 43% under its 200-day average
Insider buying
5 insiders in a week, 3rd time since 2020Traded May 29 · filed 4 days later
Since the trade −39.1% · S&P 500 −8.8% · to Nov 20
Bought 79% below the 52-week high, RSI 46, 43% under its 200-day average
Insider buying
5 insiders in a week, 3rd time since 2020Traded May 29 · filed 4 days later
Since the trade −39.1% · S&P 500 −8.8% · to Nov 20
Bought 79% below the 52-week high, RSI 46, 43% under its 200-day average
Traded Apr 15 – May 15, 2026 · largest single transaction ~$5.5K
Apr 15, 2026~$5.5K · 1,843 sh @ $2.97
DetailsOfficial recordInsider buying
5 insiders in a week, 3rd time since 2020Traded May 15 · filed 5 days later
Since the trade −47.3% · S&P 500 −6.7% · to Nov 20
Bought 75% below the 52-week high, RSI 55, 36% under its 200-day average, 25 points ahead of the S&P 500 over 3 months
Insider buying
Named in an 8-K 0 days laterTraded Apr 30 · filed 20 days later
Since the trade −42.2% · S&P 500 −4.0% · to Nov 20
Bought 77% below the 52-week high, RSI 46, 44% under its 200-day average, 18 points behind the S&P 500 over 3 months
Insider buying
5 insiders in a week, 3rd time since 2020Traded May 15 · filed 5 days later
Since the trade −47.3% · S&P 500 −6.7% · to Nov 20
Bought 75% below the 52-week high, RSI 55, 36% under its 200-day average, 25 points ahead of the S&P 500 over 3 months
The CEO of Processa Pharmaceuticals paid $5.9K out of pocket for Processa Pharmaceuticals shares. 4 other people at Processa Pharmaceuticals bought some too, in the same month. Shares held went up 25% with this purchase.
The CFO of Processa Pharmaceuticals paid $6.3K out of pocket for Processa Pharmaceuticals shares. 4 other people at Processa Pharmaceuticals bought some too, in the same month. Shares held went up 24% with this purchase.
Processa Pharmaceuticals's Chief Administrative Officer paid $4.7K out of pocket for Processa Pharmaceuticals shares. 4 other people at Processa Pharmaceuticals bought some too, in the same month. Shares held went up 20% with this purchase.
Processa Pharmaceuticals's Chief Business - Strategy Off paid $4.1K out of pocket for Processa Pharmaceuticals shares. 4 other people at Processa Pharmaceuticals bought some too, in the same month. Shares held went up 19% with this purchase.
A Processa Pharmaceuticals director paid $4.9K out of pocket for Processa Pharmaceuticals shares. 4 other people at Processa Pharmaceuticals bought some too, in the same month. Shares held went up 13% with this purchase.
The CEO of Processa Pharmaceuticals paid $5.5K out of pocket for Processa Pharmaceuticals shares. 4 other people at Processa Pharmaceuticals bought some too, in the same month. Shares held went up 25% with this purchase.
The CFO of Processa Pharmaceuticals paid $5.9K out of pocket for Processa Pharmaceuticals shares. 4 other people at Processa Pharmaceuticals bought some too, in the same month. Shares held went up 25% with this purchase.
Processa Pharmaceuticals's Chief Business - Strategy Off paid $4.1K out of pocket for Processa Pharmaceuticals shares. 4 other people at Processa Pharmaceuticals bought some too, in the same month. Shares held went up 20% with this purchase.
Processa Pharmaceuticals's Chief Administrative Officer paid $4.7K out of pocket for Processa Pharmaceuticals shares. 4 other people at Processa Pharmaceuticals bought some too, in the same month. Shares held went up 22% with this purchase.
A Processa Pharmaceuticals director paid $4.6K out of pocket for Processa Pharmaceuticals shares. 4 other people at Processa Pharmaceuticals bought some too, in the same month. Shares held went up 12% with this purchase.
May 15, 2026~$5.5K · 1,843 sh @ $2.97
DetailsOfficial recordThe CFO of Processa Pharmaceuticals paid $5.9K out of pocket for Processa Pharmaceuticals shares. 5 other people at Processa Pharmaceuticals bought some too, in the same month. Shares held went up 31% with this purchase.
Processa Pharmaceuticals's Chief Development Officer paid $5.3K out of pocket for Processa Pharmaceuticals shares. 8 other people at Processa Pharmaceuticals bought some too, in the same month. Shares held went up 36% with this purchase.
Processa Pharmaceuticals's Chief Business - Strategy Off paid $4.1K out of pocket for Processa Pharmaceuticals shares. 5 other people at Processa Pharmaceuticals bought some too, in the same month. Shares held went up 22% with this purchase.
45 open-market purchases and 0 open-market sales by insiders of PCSA between Jul 14, 2021 and today, placed against the company's last 4 earnings releases. The latest on file was filed Mar 31, 2023. The data provider lists the next release for Mar 16, 2027; that date may change.
PurchaseSale30 days before a release30 days after
| Earnings release | 30 days before | On the day | 30 days after |
|---|---|---|---|
| Mar 31, 2023 | None | None | None |
| Nov 8, 2022 | None | None | None |
| Aug 12, 2022 | None | None | None |
| Aug 13, 2021 | None | None | None |
Companies set trading windows, which usually close shortly before results and reopen after them, and insiders may trade under 10b5-1 plans adopted months earlier. A date alone does not show what a person knew or why they traded. Past release dates are the dates the company filed its 8-K with Item 2.02. An upcoming date, when one is mentioned, comes from the data provider's earnings calendar (Finnhub): it is not a company filing, it is not estimated by OQRO, and it may change. Open-market purchases and sales as reported on Form 4. Largest purchases around earnings, all companies